ID

16057

Beschreibung

Documentation part: Log Status & Randomisation Number A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Stichworte

Versionen (1)
  1. 27.06.16 27.06.16 -
Hochgeladen am

27. Juni 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Englisch

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulare  
Log Status
Beschreibung

Log Status

Did the subject experience any adverse events during the study?
Beschreibung

Did the subject experience any adverse events during the study?

Datentyp

text

Alias
UMLS CUI [1]
C0877248
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Beschreibung

Were any concomitant medications taken by the subject prior to screening and/or during the study?

Datentyp

text

Alias
UMLS CUI [1]
C2347852
Case book ready for signature
Beschreibung

CRA should check the box when data cleaning is complete. This item is used for Phase I trials only. Remove for Phase II-IV

Datentyp

text

Alias
UMLS CUI [1]
C1519316
For inform only: Do not data enter
Beschreibung

For inform only: Do not data enter

Q1
Beschreibung

Q1

Datentyp

text

Q2
Beschreibung

Q2

Datentyp

text

Randomisation Number (RAND)
Beschreibung

Randomisation Number (RAND)

Randomisation number
Beschreibung

Randomisation number

Datentyp

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C0034656
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Log Status
Item
Did the subject experience any adverse events during the study?
text
C0877248 (UMLS CUI [1])
Did the subject experience any adverse events during the study?
Code List
Did the subject experience any adverse events during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Were any concomitant medications taken by the subject prior to screening and/or during the study?
text
C2347852 (UMLS CUI [1])
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Code List
Were any concomitant medications taken by the subject prior to screening and/or during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Case book ready for signature
text
C1519316 (UMLS CUI [1])
Case book ready for signature
Code List
Case book ready for signature
CL Item
Yes (Y)
Item Group
For inform only: Do not data enter
Item
Q1
text
Q1
Code List
Q1
CL Item
Yes (Y)
CL Item
No (N)
Item
Q2
text
Q2
Code List
Q2
CL Item
PF_SC_LOST (1)
CL Item
PF_SC_DEATH (2)
CL Item
PF_SC_SPONSORDECISlON (3)
CL Item
PF_SC_PHYS[ClANDEClSlON (4)
CL Item
PF_SC_PATIENTDEClSION (5)
CL Item
PF_SC_AE (6)
CL Item
PF_SC_CRlTERIA (7)
CL Item
PF_SC_OTHER (8)
Item Group
Randomisation Number (RAND)
Randomisation number
Item
Randomisation number
integer
C0449788 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video